We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
(+10%)
Cap. Flow
+$560M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$57.5M |
| 2 |
Emerson Electric
EMR
|
+$45M |
| 3 |
Johnson & Johnson
JNJ
|
+$41.1M |
| 4 |
WEC Energy
WEC
|
+$36.5M |
| 5 |
Clorox
CLX
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$63.8M |
| 2 |
Chevron
CVX
|
+$33.9M |
| 3 |
SLB Ltd
SLB
|
+$32.7M |
| 4 |
Lam Research
LRCX
|
+$22.8M |
| 5 |
Merck
MRK
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 16.61% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 9.7% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETFC
551
DELISTED
E*Trade Financial Corporation
ETFC
| $2.76M | 0.02% |
45,805
+2,148
| +5% | +$126K |
|
552
lululemon athletica
LULU
$14.5B
| $2.75M | 0.02% |
17,266
+7,823
| +83% | +$1.07M |
|
553
Xerox
XRX
$424M
| $2.72M | 0.02% |
97,149
-527,600
| -84% | -$14M |
|
554
Vistra
VST
$48.6B
| $2.7M | 0.02% |
113,183
-102,731
| -48% | -$2.36M |
|
|
CTRA
555
DELISTED
Coterra Energy
CTRA
| $2.7M | 0.02% |
109,905
-6,360
| -5% | -$148K |
|
556
FirstEnergy
FE
$27.1B
| $2.67M | 0.02% |
69,554
-30,396
| -30% | -$1.11M |
|
557
Weyerhaeuser
WY
$18.2B
| $2.67M | 0.02% |
73,799
+8,816
| +14% | +$306K |
|
558
Bio-Techne
TECH
$11.2B
| $2.64M | 0.02% |
55,240
-1,440
| -3% | -$63.8K |
|
|
PRAH
559
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.64M | 0.02% |
25,100
-650
| -3% | -$67.7K |
|
560
Coty
COTY
$2.52B
| $2.63M | 0.02% |
205,440
+30,456
| +17% | +$394K |
|
561
Crown Castle
CCI
$31.4B
| $2.61M | 0.02% |
21,220
-38,673
| -65% | -$4.31M |
|
|
CLGX
562
DELISTED
Corelogic, Inc.
CLGX
| $2.58M | 0.02% |
51,100
| – | – |
|
|
WCG
563
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.57M | 0.02% |
8,557
-907
| -10% | -$257K |
|
|
OPTU
564
Optimum Communications Inc
OPTU
$308M
| $2.56M | 0.02% |
143,292
| – | – |
|
565
Camden Property Trust
CPT
$11B
| $2.56M | 0.02% |
26,507
+19,825
| +297% | +$1.84M |
|
566
Bio-Rad Laboratories Class A
BIO
$9.43B
| $2.56M | 0.02% |
7,850
| – | – |
|
567
Marcus & Millichap
MMI
$1.16B
| $2.56M | 0.02% |
69,889
| – | – |
|
568
Parker-Hannifin
PH
$134B
| $2.54M | 0.02% |
13,953
-72
| -0.5% | -$12.4K |
|
569
JB Hunt Transport Services
JBHT
$25B
| $2.53M | 0.02% |
20,666
+9,003
| +77% | +$1.1M |
|
570
Global Payments
GPN
$22.7B
| $2.5M | 0.01% |
19,393
-1,470
| -7% | -$177K |
|
571
Teva Pharmaceuticals
TEVA
$41.7B
| $2.5M | 0.01% |
107,987
-51,700
| -32% | -$1.2M |
|
572
Idacorp
IDA
$8.1B
| $2.49M | 0.01% |
25,333
+11,633
| +85% | +$1.12M |
|
573
Healthcare Realty
HR
$6.74B
| $2.48M | 0.01% |
+86,400
| New | +$2.38M |
|
574
Perrigo
PRGO
$1.75B
| $2.48M | 0.01% |
31,874
+615
| +2% | +$46.2K |
|
575
Ligand Pharmaceuticals
LGND
$6.33B
| $2.41M | 0.01% |
14,972
-385
| -3% | -$58K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review
As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
- DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
- DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.